purine nucleoside phosphorylase inhibitor (Institute of Organic Chemistry And Biochemistry)

N/A

Report date: 2025/06/11 10:45:28
NME

Base Information

Drug Namepurine nucleoside phosphorylase inhibitor (Institute of Organic Chemistry And Biochemistry)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsLymphoma, T-CellPrecursor T-Cell Lymphoblastic Leukemia-LymphomaParasitic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesICOB TECHNOLOGY LLCInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
Inactive CompaniesN/A
Active IndicationsLymphoma, T-CellPrecursor T-Cell Lymphoblastic Leukemia-LymphomaParasitic Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A